Rheopheresis for macular degeneration: The data is not there yet to justify it [1]

Journal of Clinical Apheresis

Volumn 20, Issue 3, 2005, Pages 168-

  Pulido, Jose S ^a   Winters, Jeffrey ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; COPPER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; VITAMIN; ZINC;

ALLELIC EXCLUSION; CANADA; HUMAN; LETTER; PLASMAPHERESIS; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA DEGENERATION; RHEOPHERESIS; SMOKING CESSATION; TREATMENT INDICATION;

ALLELES; BLOOD COMPONENT REMOVAL; COMPLEMENT FACTOR H; HUMANS; MACULAR DEGENERATION; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 30544442458     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20066     Document Type: Letter

References (5)

1. Pulido JS. Multicenter Investigation of Rheopheresis for AMD (MIRA-I) Study Group. Multicenter prospective, randomized, double-masked, placebo-controlled study of Rheopheresis to treat nonexudative age-related macular degeneration: interim analysis. Trans Am Ophthalmol Soc 2002;100:85-106; discussion 106-107.
2. Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL 3rd. Age-Related Eye Disease Study Research Group. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology 2005;112:533-539.
3. McGwin G Jr, Xie A, Owsley C. The use of cholesterol-lowering medications and age-related macular degeneration. Ophthalmology 2005;112:488-494
4. Wilson HL, Schwartz DM, Bhatt HR, McCulloch CE, Duncan JL. Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration. Am J Ophthalmol 2004;137:615-624.
5. Haines JL, Hauser MA, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Sci Express 10 March 2005. www. Scienceexpress.org.